LabCorp licenses NASH test for clinical research
LabCorp’s Covance has signed an agreement which it will use Genfit’s diagnostic test to identify and characterize patients.
Archives for January 8, 2019
Iqvia's new safety platform looks to reduce pharmacovigilance costs, complexity
Driven by a more than 20% increase in adverse event volumes, Iqvia has developed a SaaS safety platform designed to reduce the cost and complexity of pharmacovigilance activities – and help companies add value back into their business, says VP.
Upperton’s new R&D facility receives MHRA approval
Upperton Pharma’s new and expanded facilities received a positive inspection from MHRA, enabling both research and development and clinical manufacturing at the site.
Parexel launches dedicated biotech division
Parexel Biotech will support emerging companies from development through commercialization with tailored services and customized guidance, says division lead.
Portola navigates manufacturing woes to gain US approval
The company’s anticoagulant reversal treatment received a complete response letter from the FDA in 2016 but will be made available today after its approval.
Apptomics aims to establish its digital platform as the standard for monitoring movement disorders
Apptomics is working with BBK and Biotaware to develop the remote health-monitoring platform, which recently served as a digital biomarker to evaluate treatment effects as part of an essential tremor clinical trial.
GeoVax and Enesi to develop next-gen thermostable, needle-free vaccines
The two companies will combine technologies to create solid-dose, needle-free vaccines for a number of infectious diseases and emergent threat pathogens.
US FDA on-board with first inhaled treatment for Parkinson’s
FDA approved the first and only inhaled treatment for patients for the ‘most serious’ issue Parkinson’s patients face: OFF episodes.
Syneos Health: ‘Heightened influx of information’ drives 2019 trends, challenges
Access to an increasing amount of information is catalyzing research, while also lending to higher levels of professional burnout on behalf of health care professionals, says company executive.